We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

News   Nov 28, 2017 | Original story from University of Illinois

 
Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

Pretzel's brain tumor shrank more than 40 percent after treatment with PAC-1 in a clinical trial for dogs with glioma, a brain cancer very similar to glioblastoma in humans. Credit: Photo courtesy Tim Fan

 
 
 

RELATED ARTICLES

Plant Compound Has Therapeutic Effect on Complications from Snakebites

News

Researchers have found that rutin, an inexpensive, plant-based compound may protect envenomed mice from bleeding and inflammation problems, according to a study published in PLOS Neglected Tropical Diseases

READ MORE

Obesity Linked to Increased Risk of Early-Onset Colorectal Cancer

News

Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.

READ MORE

Novel Way to Generate Molecules for Drug Development

News

Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE